NeuroGT, Inc.

NeuroGT, Inc. is a biotechnology company dedicated to pioneering advancements in gene therapies. With a focus on breaking barriers to access and increasing the effectiveness of treatments, NeuroGT, Inc. is committed to transforming the landscape of care for children with neuro-genetic diseases. The company's mission centers around leveraging cutting-edge technologies to address critical unmet needs in pediatric healthcare.

Located in Research Triangle, NC, NeuroGT, Inc. is deeply involved in the research and development of innovative therapeutic solutions. The company's primary disease targets include Mucopolysaccharidoses: MPS I, MPS II, MPS IIIA, and MPS IIIB, MPS IIIC. NeuroGT, Inc. aims to deliver transformative outcomes for young patients and their families through targeted gene therapies.

NeuroGT, Inc. is poised for significant growth and commercial development within the biotechnology sector. With a clear focus on innovation and patient impact, NeuroGT, Inc. is dedicated to making a meaningful difference in the lives of children affected by neuro-genetic diseases. To the manager of NeuroGT, Inc., we invite you to create a customized and exclusive company showcase and product listing on our platform, highlighting your groundbreaking work and expanding your reach within the industry.